Show simple item record

dc.contributor.authorBond, Hannah
dc.contributor.authorMetcalf, Lisa
dc.date.accessioned2019-11-11T16:35:35Z
dc.date.available2019-11-11T16:35:35Z
dc.date.issued2019
dc.identifier.citationBond, H., Metcalf, L., Gouni, R. & Snape, S. (2019). Diabetic foot osteomyelitis treatment: an audit of success rates in differing circumstances. Diabetic Foot Journal, 22 (4), pp.17-21.en
dc.identifier.urihttp://hdl.handle.net/20.500.12904/10233
dc.description.abstractOsteomyelitis is a common complication of diabetic foot infection and is associated with a high burden of morbidity and mortality. The success rates of treatment for diabetic foot osteomyelitis treated both surgically and conservatively with antibiotics are widely documented. This study aimed primarily to establish clinical outcomes for people treated with intravenous antibiotics for diabetic foot osteomyelitis at an acute hospital in the UK.en
dc.description.urihttps://www.diabetesonthenet.com/journals/issue/596/article-details/diabetic-foot-osteomyelitis-treatment-audit-success-rates-differing-circumstancesen
dc.subjectOsteomyelitisen
dc.subjectBone diseasesen
dc.subjectMicrobiologyen
dc.subjectDiabetic footen
dc.subjectMortalityen
dc.subjectMorbidityen
dc.subjectAnti-bacterial agentsen
dc.titleDiabetic foot osteomyelitis treatment: An audit of success rates in differing circumstancesen
dc.typeArticleen


This item appears in the following Collection(s)

Show simple item record